Cells Seen; How to Tell, What to Tell; New UC Campus Hiring Scientists

TRAINING @ | Cells Seen WHAT: Immunocytochemistry, in situ hybridization & live cell imaging WHERE: Cold Spring Harbor Laboratory, Cold Spring Harbor, NY WHY: Course teaches and emphasizes the use of specialized techniques in microscopy, in situ hybridization, and immunocytochemistry ADVANTAGES: Several protocols are presented for students to assess their merits in relation to their own research WHEN: October 18-31, 2003 DEADLINE: July 15, 2003 COST: $2385 (US) CONTACT: An

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

TRAINING @ | Cells Seen

WHAT: Immunocytochemistry, in situ hybridization & live cell imaging

WHERE: Cold Spring Harbor Laboratory, Cold Spring Harbor, NY

WHY: Course teaches and emphasizes the use of specialized techniques in microscopy, in situ hybridization, and immunocytochemistry

ADVANTAGES: Several protocols are presented for students to assess their merits in relation to their own research

WHEN: October 18-31, 2003

DEADLINE: July 15, 2003

COST: $2385 (US)

CONTACT: Andrea Stephenson, 516-367-8344, stephens@cshl.edu

URL: meetings.cshl.org/2003/2003c-situ.htm

TIP TROVE | How to Tell, What to Tell

Before discussing your research with any company, at the very least, you should arrange a confidentiality disclosure agreement. The best-case scenario is to have already filed for a patent application. Scientists frequently make the mistake of believing they're meeting with company executives just to talk about science. Often times, companies want to hear what's going on, even if they don't think there's a real deal in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Mark Cohen

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours